Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02536300
Title Dose Optimization Study of Idelalisib in Follicular Lymphoma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Gilead Sciences
Age Groups: senior | adult
Covered Countries ITA | GBR | FRA | ESP | CAN | AUS

No variant requirements are available.